SGS North America Targets Five Major Trade Fairs in 2026-2027 Exhibition Calendar

SGS North America has confirmed participation in five major trade exhibitions spanning 2026 and 2027, positioning the medical device certification specialist across key industry verticals from healthcare to consumer electronics.

The company's exhibition strategy targets both established medical device shows and emerging technology sectors, reflecting its role as a full-solution provider for regulatory compliance and quality assurance. SGS operates through more than 2,700 offices and laboratories worldwide, offering medical device CE marking through its Notified Body affiliates in Belgium (1639) and Finland (0598).

Medical Device Market Focus

SGS North America's core expertise centers on medical device regulatory compliance, serving as a UK Approved Body (0120) for UKCA scheme conformity assessments in Great Britain and functioning as an Auditing Organization for MDSAP certification. The company specializes in Software as a Medical Device (SaMD) certification through its Finnish operations, addressing the growing digital health sector.

The firm's medical device services encompass training, assessment, testing and certification across the complete product lifecycle, ensuring devices meet regulatory requirements for their intended markets while maintaining consistent quality standards.

Exhibition Strategy Spans Multiple Sectors

SGS North America's 2026-2027 trade fair calendar demonstrates strategic diversification across quality and compliance sectors. The company's participation spans medical manufacturing, consumer technology, textiles, and nutritional supplements, reflecting its broad regulatory expertise.

Global Network Enables Local Expertise

The company's extensive laboratory and office network provides the infrastructure necessary to support complex regulatory requirements across multiple jurisdictions. SGS maintains specialized capabilities for medical device manufacturers seeking market access in Europe, the United Kingdom, and North America through its various regulatory body designations.

SGS North America's participation in MEDICA 2026 positions the company within the world's largest medical trade fair, while its presence at CES 2027 targets the growing convergence between consumer technology and healthcare applications. The Advanced Textiles Expo and SupplySide West appearances extend the company's reach into adjacent sectors requiring similar quality assurance protocols.

Regulatory Compliance Across Industries

Beyond medical devices, SGS North America's quality and compliance expertise serves manufacturers across industries requiring rigorous testing and certification standards. The company's multi-sector trade fair strategy reflects this broader market position while maintaining its core medical device certification leadership.

The 2026-2027 exhibition calendar represents SGS North America's commitment to face-to-face engagement with manufacturers navigating increasingly complex regulatory landscapes across multiple international markets.